| 单词 | 制药企业 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 释义 | 制药企业 —pharmaceutical companySee also:制药 adj—pharmaceutic adj 制药—manufacture medicine 制药业—pharmaceutical industry 企业 n—companies pl • company n • enterprise n • corporation n • operation n • undertaking n
|
本篇报告以潜在投资者的视角，重点关注国内 外 制药企业 及 其 在中国市场上的业务活动。 deloitte.com | This report focuses [...] in particular on pharmaceuticals companies, both domestic [...]and foreign, and their activities in the China [...]market—all from the viewpoint of prospective investors. deloitte.com |
作为一家具有多年经验和核心技术的 [...] CRO，该公司主要业务为 PVC (制药价值创造商) 活动，包括支持制药企业价值链的 CMO 和 CSO。 mdsol.com | Capitalizing on the long years of experience and know-how as a CRO, it engages mainly in PVC [...] (Pharmaceutical Value Creator) activities including CMO and CSO, in support of the [...] value chains of pharmaceutical companies. mdsol.com |
她曾担任全球客户经理，随后担任生命科学质量控制经理，从事大客户发展（包括全球前 10 位 制药企业 ） 业 务开发工作。 sgsgroup.com.cn | She was Global Key Account Manager and then Life Sciences Quality [...] Control Manager for the business development of major key accounts, including [...] the top 10 global pharmaceutical leaders. sgsgroup.com.ar |
预料之中的是，新的体系（特别是它的三大支柱： “固定价格-固定利润”制度、限制 制药企业 之 间的合作以及 企业将有额外的经济负担）影响到了大部分在波兰开展业务的 [...] 制药公司。 paiz.gov.pl | As expected, the new system (especially its three cornerstones: the “fixed prices – fixed [...] margins” regime, restrictions on [...] cooperation between players in the pharmaceutical market and additional [...]financial burdens for [...]businesses) affected the majority of pharma companies working in Poland. paiz.gov.pl |
Cegedim Dendrite（粉单交易市场：CGMJF）宣布与领先 的 制药企业 s a n of i-aventis签署了一份为期3年的协议，向包括美国、法国和日本在内的28个国家的2万名用户提供移动智能客户关系管理（CRM）解决方案。 tipschina.gov.cn | Cegedim Dendrite (PINKSHEETS: CGMJF), global leader in Customer Relationship Management for the life sciences [...] industry, announces a 3 year [...] agreement with leading pharmaceutical company sanofi-aventis [...]to provide Mobile Intelligence [...]CRM solution to over 20 000 users across 28 countries including USA, France and Japan. tipschina.gov.cn |
公司客户群多样，遍及生物制药企业 、 医 疗器械和诊断公司、学术和政府机构、CRO 和其他研究组织，包括前 25 强全球性制药企业中的20 多家，以及开发提升生命质量的医疗、诊断技术的各种规模的机构。 mdsol.com | Our diverse [...] customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as [...]organizations of all sizes [...]developing life-enhancing medical treatments and diagnostics. mdsol.com |
Synteract公司成立于1995年，是一家提供全套服务的私有 合同研究组织, 致力于满足生物技术、医疗器械和 制药企业 的 临 床需求。 mdsol.com | Established in 1995, Synteract is a privately held, full-service contract [...] research organization, dedicated to meeting the clinical needs of biotechnology, [...] medical device, and pharmaceutical companies. mdsol.com |
2011年大会将聚集行业重要人士，包括医院主管、IT创新者、公立和私立医疗保险基金决策制定者 、 制药企业 、 医 疗服务提供商、卫生部长、以及政府首脑。 tipschina.gov.cn | The 2011 Congress will feature the top industry influencers including hospital directors, IT innovators, [...] decision makers from public and private [...] insurance funds, pharmaceutical and medical device [...]companies, health care industry suppliers, [...]health ministers, and leading government officials. tipschina.gov.cn |
因此，制药企业的原 材料或者工艺管理很重要，对此是如何进行管理的呢？ smartfactory.lgcns.com | Hence, material or process management are very [...] important with pharmaceutical companies. smartfactory.lgcns.com |
丰田通商株式会社表示，与GNT合作将有助于丰田通商株式会社通过自己多年经营的日本国内网络，向日本领先 的 制药企业 提 供 更好的以客户为导向的业务。 tipschina.gov.cn | According to TTC, the collaboration with GNT will enable TTC [...] to provide more customer-oriented business to [...] Japanese leading pharmaceutical manufacturers through [...]the domestic network [...]which TTC has established so far. tipschina.gov.cn |
sanofi-aventis是一家领先的全球化 制药企业 ， 公 司发现、开发和分销治疗解决方案，改善人们的生活。 tipschina.gov.cn | Sanofi-aventis, a [...] leading global pharmaceutical company, discovers, [...]develops and distributes therapeutic solutions to improve the lives of everyone. tipschina.gov.cn |
在短短的两三年时间内，嘉和公司已经在几个关键业务上取得了重要进展：2011年 2月，嘉和公司与一家全球500强跨国 制药企业 签 订 了第一份国际医药制造外包（CMO）业务合同；2011年5月，公司第一个生物仿制药GB221项目向国家食品药品监督管理局申报临床批件，并通过上海食品药品监督局的现场核查；GB221在澳大利亚的国际I期临床试验也已顺利完成。 wison.com | In May 2011, Genor finished IND filing of the first biosimilar GB221 for approval of SFDA and passed the on-site verification of the Shanghai Food and Drug Administration. wison.com |
2011年10月26日，日内瓦—世界知识产权组织(WIPO)今天与多家领 先 制药企业 和 生 物技术产业组织全球卫生事业机构(BVGH)开始了一次前所未有的合作，启动了WIPO [...] Re:Search。 wipo.int | GENEVA, October 26, 2011 – The World Intellectual Property Organization [...] (WIPO), in an unprecedented [...] collaboration with leading pharmaceutical companies and BIO Ventures [...]for Global Health (BVGH), launched [...]today WIPO Re:Search, a new consortium where public and private sector organizations share valuable intellectual property (IP) and expertise with the global health research community to promote development of new drugs, vaccines, and diagnostics to treat neglected tropical diseases, malaria, and tuberculosis. wipo.int |
中国制药企业在药品降价和政策调整的风风雨雨中度过了2006年。 rolandberger.com.cn | China’s pharmaceutical enterprises experienced declining drug [...] price and policy adjustment in 2006. rolandberger.com.cn |
为展示新修订药品GMP实施的成果，分享优秀企业的成功经验，CHINA-PHARM 2012还将推出“新修订药品GMP成果展”，通过生动的案例和丰富的展示手段，推动中 国 制药企业 改 造 生产条件，做好生产管理软件的升级换代，促进产业升级和结构调整，不断提高药品生产质量管理能力和质量控制水平。 china-pharm.net | In order to present the achievements of newly revised drug GMP, share the successful experience of the outstanding enterprises, [...] CHINA-PHARM 2012 will [...] present “Drug GMP Achievements Showcase Zone” to help Chinese pharmaceutical manufacturers improve the [...]production conditions [...]and update the production management software, facilitate industrial upgrading and structural adjustment, as well as continuously enhance the pharmaceutical production and quality management capacity and quality control level. china-pharm.net |
全球制药企业、生 物技术和医疗器械公司、合同研究组织和其他负责预算编制和临床试验管理的机构广泛采用 [...] Grants Manager 和 CRO Contractor。 mdsol.com | Grants Manager and CRO Contractor are [...] used globally by pharmaceutical, biotechnology [...]and medical device companies as well [...]as contract research organizations and others responsible for budgeting and managing clinical trials. mdsol.com |
公司在药理学、药理成像和医药化学领域的技术专长，以及强大的项目管理能力，是公司在实验和发现这两大战略活动上的支柱，公司的实验和发现活动是 和 制药企业 、 生 物技术企业合作开展的。 tipschina.gov.cn | Its scientific expertise in pharmacology, imaging and medicinal chemistry, in addition to strong project management skills, support the company's two [...] strategic activities of experimentation and discovery, conducted in [...] partnership with pharmaceutical and biotechnology [...]companies. tipschina.gov.cn |
这些品质保证措施对支持在全球拥有多家分支机构的大 型 制药企业 来 说 尤其重要，因为这类企业要求提供性能一致的动物，以降低研究结果产生偏差的可能性。 tipschina.gov.cn | These quality processes are particularly important [...] to support large pharmaceutical companies with multiple [...]sites throughout the world, which [...]require supply of consistent animals to reduce potential variation in research results. tipschina.gov.cn |
大多数生物制药企业的高 管一致认为，现有的创新模式已被打破。 tipschina.gov.cn | Most biopharma executives agree that the [...] current model for innovation is broken. tipschina.gov.cn |
一组全球公认的优秀机构作为WIPO Re:Search的提供方、潜在的使用方和支助方(见附件)，加入八家参与发起 的 制药企业 、 WI PO、BVGH和美国国立卫生研究院，共同进行这一事业。 wipo.int | The founding eight pharmaceutical companies, WIPO, BVGH, and NIH are joined by a distinguished group of globally recognized institutions as providers, potential users, and supporters of WIPO Re:Search (see annex). wipo.int |
Medidata [...] 的客户有制药、生物技术和医疗器械公司，学术研究所，CRO 和其他研究组织，以及前 25 强跨国制药企业的 20 多家。 mdsol.com | Medidata’s diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic [...] institutions, CROs and other research organizations, and includes more than 20 of [...] the top 25 global pharmaceutical companies. mdsol.com |
另外还一直给制造企业提供自动仓库，工厂内的物流设备， 为 制药企业 提 供 药品自动仓库等，在多个领域提供最优解决方案及相关装置的设计和制作。 smartfactory.lgcns.com | We have also designed, developed, and provided optimization solutions and related equipment in various fields such as automated warehouses of manufacturers, distribution facilities within factories, and medicine warehouses of pharmaceutical companies. smartfactory.lgcns.com |
无论是大型制药企业，还 是中间市场公司，或是小型生物技术公司，在2007 年，Medidata 公司都向 其充分证明了自己作为一家临床技术伙伴的重要地位。 mdsol.com | From big pharmas to mid-market companies to smaller biotechs, Medidata in 2007 further demonstrated its position as a key clinical technology partner. mdsol.com |
印度制药企业，在 印度及亚洲、非洲、CIS 以及拉丁美洲多个半管制市场销售内部研发的非专利品牌产品，同时为管制市场（美国及欧洲）代工生产和销售普通制剂。 china.blackstone.com | Indian pharmaceutical company engaged in selling [...] in-house developed, branded generic products in India and several semi-regulated [...]markets in Asia, Africa, CIS and Latin America, contract manufacturing and sale of generic formulations for regulated markets (U.S. and Europe). blackstone.com |
将 Rave 技术引进公司内部之后，Axcan [...] 公司将更方便地在公司内部掌控、构建、管理及实施各项研究，从而使这 家 制药企业 能 够 更好地掌控其核心的临床研究项目。 mdsol.com | Bringing Rave skills in-house will give Axcan the opportunity to control, build, [...] manage and administer studies [...] internally, giving the pharmaceutical greater control [...]of their vital clinical research programs. mdsol.com |
康道灵芝孢子油是香港001集团在“超临界CO2萃取加分子蒸馏理论纯化技术”这一全新灵芝孢子油研发核心工艺的指引下，通过与相关研究机构 、 制药企业 的 强 强联合，先通过超临界CO2萃取提取灵芝孢子的脂溶性物质，然后用分子蒸馏理论纯化技术对所得到的物质进行分离、纯化，使灵芝三萜等抗癌最有效的含量富集，从而成功研制出新一代灵芝孢子油 。 dbslz.com | Kang Dao Ganoderma Lucidum spore oil is under the guidance of the newest Ganoderma lucidum spore oil core researching craft "supercritical CO2 extraction and molecular distillation theoretical purification technology" by Hong Kong 001 Group, through the [...] combination of the relevant research [...] institutions and pharmaceutical enterprise, firstly extracted [...]the fat-soluble compounds of [...]lingzhi spores by supercritical CO2 extraction, then separated, purified the fat-soluble compounds by molecular distillation theoretical purification technology, made the gatherings of most effective content against cancer like ganoderma lucidum triterpenes, etc., thus successfully developed a new generation of ganoderma lucidum spore oil. dbslz.com |
到2009年年底，排在前20位的注册人是：汉高（德国）、诺华（瑞士）、杨 森 制药 （ 比利时）、欧莱雅（法国）、雀巢（瑞士）、联合利华（荷兰）、 I T M 企业 （ 法 国）、巴斯夫（德国）、赛诺菲–安万特（法国）、西门子（德国）、利得（德国）、拜尔（德国）、Biofarma（法国）、勃林格殷格翰（德国）、吉瑞大药厂（匈牙利）、先正达（瑞士）、飞利浦（荷兰）、艺康（德国）、默克（德国）、赫佛（奥地利） [...] [...] 和德国电信（德国）。 wipo.int | The top twenty holders by the end of 2009 were: Henkel [...] (Germany), Novartis [...] (Switzerland), Janssen Pharmaceutica (Belgium), l’Oréal (France), Nestlé (Switzerland), Unilever (Netherlands), ITM Enterprises (France), BASF (Germany), [...]Sanofi-Aventis (France), [...]Siemens (Germany), Lidl (Germany), Bayer (Germany), Biofarma (France), Boehringer Ingelheim (Germany), Richter Gedeon (Hungary), Syngenta (Switzerland), Philips (Netherlands), Ecolab (Germany), Merck (Germany), Hofer (Austria) and Deutsche Telekom (Germany). wipo.int |
(e) 鼓励在所有各级作出安排并制定奖励措施，调动各商 业 企业 ， 尤其 是制 药业，投 资开展研究，探讨以负担得起的价格治疗发展中国家老年人尤其易患的 疾病的方法，请世界卫生组织考虑增进公、私部门在保健研究方面的伙伴关系。 monitoringris.org | (e) Encourage, at all levels, arrangements [...] and incentives to [...] mobilize commercial enterprises, especially pharmaceutical enterprises, to invest [...]in research aimed at finding [...]remedies that can be provided at affordable prices for diseases that particularly afflict older persons in developing countries and invite the World Health Organization to consider improving partnerships between the public and private sectors in the area of health research. monitoringris.org |
英汉双解词典包含2273206条英汉词条，基本涵盖了全部常用单词的翻译及用法，是英语学习的有利工具。